IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024
LAWRENCEVILLE, N.J., March 21, 2024 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated…